Logo image of NUE

NUCOR CORP (NUE) Stock Fundamental Analysis

USA - NYSE:NUE - US6703461052 - Common Stock

136.97 USD
+3.32 (+2.48%)
Last: 10/13/2025, 8:04:00 PM
135.2 USD
-1.77 (-1.29%)
Pre-Market: 10/14/2025, 4:22:44 AM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to NUE. NUE was compared to 156 industry peers in the Metals & Mining industry. NUE has an excellent profitability rating, but there are some minor concerns on its financial health. NUE has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year NUE was profitable.
NUE had a positive operating cash flow in the past year.
Each year in the past 5 years NUE has been profitable.
In the past 5 years NUE always reported a positive cash flow from operatings.
NUE Yearly Net Income VS EBIT VS OCF VS FCFNUE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

1.2 Ratios

NUE has a Return On Assets of 3.77%. This is in the better half of the industry: NUE outperforms 71.79% of its industry peers.
With a decent Return On Equity value of 6.33%, NUE is doing good in the industry, outperforming 71.15% of the companies in the same industry.
The Return On Invested Capital of NUE (5.64%) is better than 64.74% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NUE is significantly above the industry average of 12.18%.
The 3 year average ROIC (17.84%) for NUE is well above the current ROIC(5.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.77%
ROE 6.33%
ROIC 5.64%
ROA(3y)14.01%
ROA(5y)14.38%
ROE(3y)24.2%
ROE(5y)25.55%
ROIC(3y)17.84%
ROIC(5y)19.27%
NUE Yearly ROA, ROE, ROICNUE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

NUE has a better Profit Margin (4.19%) than 69.87% of its industry peers.
NUE's Profit Margin has improved in the last couple of years.
NUE's Operating Margin of 6.99% is fine compared to the rest of the industry. NUE outperforms 60.90% of its industry peers.
NUE's Operating Margin has improved in the last couple of years.
The Gross Margin of NUE (10.43%) is comparable to the rest of the industry.
NUE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 6.99%
PM (TTM) 4.19%
GM 10.43%
OM growth 3Y-27.6%
OM growth 5Y2.16%
PM growth 3Y-29.36%
PM growth 5Y3.25%
GM growth 3Y-23.78%
GM growth 5Y2.32%
NUE Yearly Profit, Operating, Gross MarginsNUE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NUE is creating value.
Compared to 1 year ago, NUE has less shares outstanding
Compared to 5 years ago, NUE has less shares outstanding
NUE has a worse debt/assets ratio than last year.
NUE Yearly Shares OutstandingNUE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NUE Yearly Total Debt VS Total AssetsNUE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

NUE has an Altman-Z score of 4.00. This indicates that NUE is financially healthy and has little risk of bankruptcy at the moment.
NUE has a Altman-Z score (4.00) which is in line with its industry peers.
NUE has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of NUE (0.34) is worse than 66.03% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 4
ROIC/WACC0.61
WACC9.26%
NUE Yearly LT Debt VS Equity VS FCFNUE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

A Current Ratio of 2.83 indicates that NUE has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.83, NUE is in line with its industry, outperforming 58.33% of the companies in the same industry.
NUE has a Quick Ratio of 1.51. This is a normal value and indicates that NUE is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.51, NUE is in line with its industry, outperforming 48.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 1.51
NUE Yearly Current Assets VS Current LiabilitesNUE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

The earnings per share for NUE have decreased strongly by -55.80% in the last year.
NUE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.91% yearly.
The Revenue has decreased by -5.78% in the past year.
Measured over the past years, NUE shows a small growth in Revenue. The Revenue has been growing by 6.35% on average per year.
EPS 1Y (TTM)-55.8%
EPS 3Y-27.81%
EPS 5Y15.91%
EPS Q2Q%-1.12%
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y-5.56%
Revenue growth 5Y6.35%
Sales Q2Q%4.69%

3.2 Future

Based on estimates for the next years, NUE will show a small growth in Earnings Per Share. The EPS will grow by 4.45% on average per year.
Based on estimates for the next years, NUE will show a small growth in Revenue. The Revenue will grow by 5.80% on average per year.
EPS Next Y-5.45%
EPS Next 2Y14.21%
EPS Next 3Y15.9%
EPS Next 5Y4.45%
Revenue Next Year6.64%
Revenue Next 2Y5.96%
Revenue Next 3Y5.8%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NUE Yearly Revenue VS EstimatesNUE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10B 20B 30B 40B
NUE Yearly EPS VS EstimatesNUE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

4

4. Valuation

4.1 Price/Earnings Ratio

NUE is valuated rather expensively with a Price/Earnings ratio of 22.34.
Based on the Price/Earnings ratio, NUE is valued a bit cheaper than the industry average as 78.85% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.34. NUE is around the same levels.
A Price/Forward Earnings ratio of 11.87 indicates a reasonable valuation of NUE.
Based on the Price/Forward Earnings ratio, NUE is valued a bit cheaper than the industry average as 78.85% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.86. NUE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 22.34
Fwd PE 11.87
NUE Price Earnings VS Forward Price EarningsNUE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NUE is valued a bit cheaper than the industry average as 78.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.77
NUE Per share dataNUE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The excellent profitability rating of NUE may justify a higher PE ratio.
A more expensive valuation may be justified as NUE's earnings are expected to grow with 15.90% in the coming years.
PEG (NY)N/A
PEG (5Y)1.4
EPS Next 2Y14.21%
EPS Next 3Y15.9%

6

5. Dividend

5.1 Amount

NUE has a Yearly Dividend Yield of 1.59%.
NUE's Dividend Yield is rather good when compared to the industry average which is at 2.41. NUE pays more dividend than 82.69% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.44, NUE is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.59%

5.2 History

The dividend of NUE is nicely growing with an annual growth rate of 6.08%!
NUE has been paying a dividend for at least 10 years, so it has a reliable track record.
NUE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)6.08%
Div Incr Years34
Div Non Decr Years34
NUE Yearly Dividends per shareNUE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

NUE pays out 39.96% of its income as dividend. This is a sustainable payout ratio.
NUE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP39.96%
EPS Next 2Y14.21%
EPS Next 3Y15.9%
NUE Yearly Income VS Free CF VS DividendNUE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B
NUE Dividend Payout.NUE Dividend Payout, showing the Payout Ratio.NUE Dividend Payout.PayoutRetained Earnings

NUCOR CORP

NYSE:NUE (10/13/2025, 8:04:00 PM)

Premarket: 135.2 -1.77 (-1.29%)

136.97

+3.32 (+2.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-28 2025-07-28/amc
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners77.34%
Inst Owner Change0.01%
Ins Owners0.45%
Ins Owner Change-0.15%
Market Cap31.44B
Analysts80
Price Target159.92 (16.76%)
Short Float %2.32%
Short Ratio3.08
Dividend
Industry RankSector Rank
Dividend Yield 1.59%
Yearly Dividend2.18
Dividend Growth(5Y)6.08%
DP39.96%
Div Incr Years34
Div Non Decr Years34
Ex-Date09-30 2025-09-30 (0.55)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)8.09%
Min EPS beat(2)-1.2%
Max EPS beat(2)17.38%
EPS beat(4)3
Avg EPS beat(4)25.32%
Min EPS beat(4)-1.2%
Max EPS beat(4)84.88%
EPS beat(8)6
Avg EPS beat(8)15.34%
EPS beat(12)9
Avg EPS beat(12)12.8%
EPS beat(16)11
Avg EPS beat(16)10.29%
Revenue beat(2)1
Avg Revenue beat(2)2.72%
Min Revenue beat(2)-1.93%
Max Revenue beat(2)7.36%
Revenue beat(4)3
Avg Revenue beat(4)2.57%
Min Revenue beat(4)-1.93%
Max Revenue beat(4)7.36%
Revenue beat(8)5
Avg Revenue beat(8)1.96%
Revenue beat(12)7
Avg Revenue beat(12)1.33%
Revenue beat(16)9
Avg Revenue beat(16)0.86%
PT rev (1m)2.05%
PT rev (3m)7.7%
EPS NQ rev (1m)-13.82%
EPS NQ rev (3m)-16.24%
EPS NY rev (1m)-1.98%
EPS NY rev (3m)0.08%
Revenue NQ rev (1m)-2.15%
Revenue NQ rev (3m)-2.25%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 22.34
Fwd PE 11.87
P/S 1.02
P/FCF N/A
P/OCF 10.04
P/B 1.54
P/tB 2.4
EV/EBITDA 9.77
EPS(TTM)6.13
EY4.48%
EPS(NY)11.54
Fwd EY8.43%
FCF(TTM)-1.68
FCFYN/A
OCF(TTM)13.64
OCFY9.96%
SpS134.21
BVpS88.83
TBVpS57
PEG (NY)N/A
PEG (5Y)1.4
Profitability
Industry RankSector Rank
ROA 3.77%
ROE 6.33%
ROCE 7.16%
ROIC 5.64%
ROICexc 6.14%
ROICexgc 8.34%
OM 6.99%
PM (TTM) 4.19%
GM 10.43%
FCFM N/A
ROA(3y)14.01%
ROA(5y)14.38%
ROE(3y)24.2%
ROE(5y)25.55%
ROIC(3y)17.84%
ROIC(5y)19.27%
ROICexc(3y)21.93%
ROICexc(5y)23.06%
ROICexgc(3y)31.53%
ROICexgc(5y)31.51%
ROCE(3y)22.62%
ROCE(5y)24.46%
ROICexcg growth 3Y-36.34%
ROICexcg growth 5Y-0.84%
ROICexc growth 3Y-38.58%
ROICexc growth 5Y-3.14%
OM growth 3Y-27.6%
OM growth 5Y2.16%
PM growth 3Y-29.36%
PM growth 5Y3.25%
GM growth 3Y-23.78%
GM growth 5Y2.32%
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 1.9
Cap/Depr 243.65%
Cap/Sales 11.41%
Interest Coverage 250
Cash Conversion 87.02%
Profit Quality N/A
Current Ratio 2.83
Quick Ratio 1.51
Altman-Z 4
F-Score4
WACC9.26%
ROIC/WACC0.61
Cap/Depr(3y)202.33%
Cap/Depr(5y)198.22%
Cap/Sales(3y)7.13%
Cap/Sales(5y)6.7%
Profit Quality(3y)85.27%
Profit Quality(5y)96.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-55.8%
EPS 3Y-27.81%
EPS 5Y15.91%
EPS Q2Q%-1.12%
EPS Next Y-5.45%
EPS Next 2Y14.21%
EPS Next 3Y15.9%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-5.78%
Revenue growth 3Y-5.56%
Revenue growth 5Y6.35%
Sales Q2Q%4.69%
Revenue Next Year6.64%
Revenue Next 2Y5.96%
Revenue Next 3Y5.8%
Revenue Next 5YN/A
EBIT growth 1Y-53.7%
EBIT growth 3Y-31.62%
EBIT growth 5Y8.65%
EBIT Next Year49.97%
EBIT Next 3Y25.02%
EBIT Next 5Y19.61%
FCF growth 1Y-105.98%
FCF growth 3Y-44.08%
FCF growth 5Y-9.56%
OCF growth 1Y-63.03%
OCF growth 3Y-13.89%
OCF growth 5Y7.21%